Editorial: recognising the efficacy of licensed drug therapies for irritable bowel syndrome on bloating—a step in the right direction for targeted treatment? Authors' reply

LINKED CONTENT This article is linked to Nelson et al and Vasant papers. To view these articles, visit https://doi.org/10.1111/apt.16437 and https://doi.org/10.1111/apt.16440

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2021-07, Vol.54 (2), p.198-199
Main Authors: Nelson, Alfred D., Black, Christopher J., Houghton, Lesley A., Lugo‐Fagundo, Nahyr Sofía, Lacy, Brian E., Ford, Alexander C.
Format: Article
Language:English
Subjects:
Drug therapy
Irritable bowel syndrome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:LINKED CONTENT This article is linked to Nelson et al and Vasant papers. To view these articles, visit https://doi.org/10.1111/apt.16437 and https://doi.org/10.1111/apt.16440
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.16443